التفاصيل البيبلوغرافية
| العنوان: |
Lichen planus pemphigoides during therapy with tislelizumab and sitravatinib in a patient with metastatic lung cancer. |
| المؤلفون: |
Mar A., Kerkemeyer K.L.S., Lai F.Y.X. |
| بيانات النشر: |
Blackwell Publishing Australia 2020-06-04 |
| نوع الوثيقة: |
Electronic Resource |
| مصطلحات الفهرس: |
betamethasone/pv [Special Situation for Pharmacovigilance], sitravatinib/pv [Special Situation for Pharmacovigilance], tislelizumab/ae [Adverse Drug Reaction], tislelizumab/dt [Drug Therapy], tislelizumab/iv [Intravenous Drug Administration], tislelizumab/pv [Special Situation for Pharmacovigilance], lichen planus pemphigoides/di [Diagnosis], lichen planus pemphigoides/dt [Drug Therapy], lichen planus pemphigoides/si [Side Effect], erythema, female, histopathology, human, human tissue, immunofluorescence test, inflammatory infiltrate, letter, lichen planus/di [Diagnosis], lichen planus/dt [Drug Therapy], lichen planus/si [Side Effect], lung adenocarcinoma/dt [Drug Therapy], maculopapular rash/dt [Drug Therapy], maculopapular rash/si [Side Effect], metastasis/dt [Drug Therapy], multiple cycle treatment, parakeratosis, pruritus/si [Side Effect], rash/si [Side Effect], stria, betamethasone/dt [Drug Therapy], betamethasone/tp [Topical Drug Administration], complement component C3/ec [Endogenous Compound], emollient agent/dt [Drug Therapy], emollient agent/pv [Special Situation for Pharmacovigilance], emollient agent/tp [Topical Drug Administration], immunoglobulin G/ec [Endogenous Compound], pembrolizumab/ae [Adverse Drug Reaction], pembrolizumab/dt [Drug Therapy], pembrolizumab/iv [Intravenous Drug Administration], pembrolizumab/pv [Special Situation for Pharmacovigilance], pembrolizumab/tm [Unexpected Outcome of Drug Treatment], prednisolone/dt [Drug Therapy], prednisolone/po [Oral Drug Administration], prednisolone/pv [Special Situation for Pharmacovigilance], sitravatinib/dt [Drug Therapy], sitravatinib/po [Oral Drug Administration], acanthosis, aged, blister/si [Side Effect], case report, clinical article, drug withdrawal, Letter |
| URL: |
https://repository.monashhealth.org/monashhealthjspui/handle/1/35367
Australasian Journal of Dermatology
Click here for full text options
LibKey Link |
| الإتاحة: |
Open access content. Open access content
Copyright 2020 Elsevier B.V., All rights reserved. |
| أرقام أخرى: |
AUSHL oai:repository.monashhealth.org:1/35367
Australasian Journal of Dermatology. 61 (2) (pp 180-182), 2020. Date of Publication: 01 May 2020.
0004-8380
https://repository.monashhealth.org/monashhealthjspui/handle/1/35367
Kerkemeyer, Karolina Louisa Suzanna; ORCID: http://orcid.org/0000-0001-9367-2348
31808542 [http://www.ncbi.nlm.nih.gov/pubmed/?term=31808542]
2003820512
(Kerkemeyer, Lai, Mar) Department of Dermatology, Monash Health, Clayton, VIC, Australia
Kerkemeyer K.L.S.; karolina.kerkemeyer@live.com
1305138362 |
| المصدر المساهم: |
MONASH HEALTH LIBRS
From OAIster®, provided by the OCLC Cooperative. |
| رقم الأكسشن: |
edsoai.on1305138362 |
| قاعدة البيانات: |
OAIster |
